Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen
Ebba Samuelsson, Carolina Gustafsson, Lindvi Gudmundsdotter, Ekaterina Mirgorodskaya, Jonas Nilsson, Maria Ekblad, Beata Adamiak, Eva Jennische, Stefan Lange, Edward Trybala, Staffan Görander, Tomas B. Bergström, Jan‐Åke Liljeqvist, Rickard Nordén
This study shows that HSV-2 glycoprotein G (mgG-2) is critical for neuroinvasion and that its glycosylation is essential for vaccine efficacy against HSV-2.
PLoS Pathogens · Jul 9, 2026Peer-reviewedMicrobiology